Remedial Health

remedial.health →

-56%

est. 2Y upside i

HealthcareSeries A

B2B E-commerce & Fintech platform for Pharmacies & Hospitals in Africa

Rank

#953

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Remedial Health presents a compelling equity opportunity with strong upside potential, driven by its position as Africa's fastest-growing HealthTech company in a massive and underserved pharmaceutical market.

Last updated: March 10, 2026

Bull (27%)+300%

Remedial Health significantly expands its market penetration across Nigeria and successfully enters 1-2 new key African markets, leveraging its 'Fastest-Growing HealthTech Company' status and strong network effects. Enhanced embedded financing offerings drive higher revenue per customer, pushing annual revenue to $100M+ by 2028 and justifying a $500M+ valuation (5x current) as a clear market leader.

Base (50%)+50%

Remedial Health maintains its strong growth trajectory within Nigeria, expanding its customer base to over 14,000 healthcare providers and deepening its product offerings. Revenue grows steadily to ~$50M by 2028, leading to a valuation of approximately $200M (1.5x current) as it solidifies its position in the fragmented market.

Bear (23%)-75%

Increased competition from well-funded regional players and regulatory hurdles slow market expansion and growth. The company struggles to maintain its gross margin of ~40% due to pricing pressure, and a challenging funding environment leads to a down round, resulting in a valuation of ~$33M (0.25x current) and significant loss of common stock value.

Est. time to liquidity~3.5 years

Preference Stack Risk

moderate

Investors hold approximately $17M in liquidation preferences, which is about 12.87% of the estimated current $132M valuation.

Dilution Risk

high

As a Series A company, several more funding rounds (Series B, C, etc.) are likely needed before an exit, which will lead to further dilution for common shareholders.

Secondary Liquidity

none

Given the company's Series A stage, there is currently no active secondary market or tender offers for employee equity.

View all 2 open roles at Remedial Health →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Remedial Health's data — designed to show you've done your homework.

  • 1

    “Given the 'medium' incumbent threat and 'moderate' competitive moat, how does Remedial Health plan to further differentiate its platform and embedded financial services to fend off both traditional distributors and emerging tech competitors?”

  • 2

    “With $33M in revenue and being recognized as Africa's fastest-growing HealthTech company, what are the key strategic priorities for the next 18-24 months to maintain this growth trajectory and expand beyond Nigeria?”

  • 3

    “As a Series A company with a moderate preference stack, what is the company's long-term vision for liquidity for employees, and what are the anticipated milestones for future funding rounds or an exit?”

Community

Valuation Sentiment

Our model estimates -56% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.